3-descladinose-2,3-anhydroerythromycin derivatives

Details 3-descladinose-2,3-anhydroerythromycin derivatives 3-descladinose-2,3-anhydroerythromycin derivatives

1997-04-04

1998-05-12

Kunz, Gary L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 71, 536 186, A01N 4304, C07H 1708

Patent

active

057505101

ABSTRACT:
Novel 3-descladinose-2,3-anhydroerythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity.

REFERENCES:
Journal of Antibiotics, vol. 43, No. 11 (1990), pp. 1508-1511, H. Susuki et al., "Biosynthesis of Mycinamicins by a Blocked Mutant of Micromonospora Griseorubida".
Journal of the Chemical Society Perkin Trans. I, No. 6 (1987), pp. 1189-1209, A.G. Fishman et al "Novel Semisynthetic Oxa and Alkyl Macrolike Antibacterials and Related Derivatives".
Chemical Abstract, vol. 120 (1994) 218423h.
Chemical Abstract, vol. 120 (1994) 77599f.
Chemical Abstract, vol. 122 (1995) 240349b.
Chemical Abstract, vol. 117 (1992) 251713p.

Affiliated with

Also associated with

Rating

3-descladinose-2,3-anhydroerythromycin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-descladinose-2,3-anhydroerythromycin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-descladinose-2,3-anhydroerythromycin derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-979141